- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03460574
Targeting Cognitive Immunization in Depression
August 22, 2018 updated by: Philipps University Marburg Medical Center
How Can Change of Dysfunctional Expectations in Major Depression be Enhanced? An Experimental Study Targeting Cognitive Immunization
Research has shown that people suffering from MDD tend to maintain dysfunctional expectations despite experiences that disconfirm expectations.
Recently, it has been shown that this persistence of expectations is due to maladaptive information processing involving "cognitive immunization".
This experimental study aims at testing three different strategies to inhibit cognitive immunization, in order to enhance expectation change.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
It appears adaptive to change one's expectations when continuously gaining expectation-disconfirming experiences; however, research has shown that people suffering from MDD have difficulty in changing their expectations after experiences that disconfirm expectations.
Recently, the investigators have shown that this persistence of expectations is due to maladaptive information processing involving "cognitive immunization", defined as a cognitive reappraisal of expectation-disconfirming experiences in such a way that the individual's expectations are maintained.
In view of psychotherapeutic interventions aiming to modify patients' dysfunctional expectations, effective strategies to inhibit cognitive immunization strategies need to be identified.
Therefore, the aim of this study was to compare different immunization-inhibiting strategies with regard to their effectivity in enhancing expectation change.
For this purpose, the investigators use a standardized experimental paradigm, which was developed and validated in a previous study.
Study Type
Interventional
Enrollment (Actual)
135
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hessen
-
Bad Arolsen, Hessen, Germany, 34454
- Schoen Klinik Bad Arolsen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- current diagnosis of Major Depressive Disorder
- at least 18 years old
- sufficient German language knowledge
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: INFORMATION
Participants in this condition receive a manipulation suggesting that the performance test "TEMINT", they previously worked on, has been shown to be highly relevant for daily life and professional success.
We anticipated that after receiving this fake information about the TEMINT, it would be difficult for participants to engage in cognitive immunization processes because the validity and utility of the expectation-disconfirming experience is explicitly highlighted.
|
After receiving expectation-disconfirming positive performance feedback, participants receive standardized information that stresses the relevance of this experience.
In particular, participants are told that the performance test they worked on is highly relevant for both professional success and personal life satisfaction.
|
|
EXPERIMENTAL: SALIENCE
Participants in this condition are asked to think about how well they performed on this really difficult performance test.
We anticipated that this manipulation would enhance expectation change, as the salience of the expectation-disconfirming experience was explicitly increased.
|
After receiving expectation-disconfirming positive performance feedback, partcipants in this condition are instructed to remember how well they performed on the performance test.
Using a visual analogue scale, they were asked to specify how they performed relative to the other participants.
|
|
EXPERIMENTAL: ATTENTION
Before working on the performance test, participants in this conditions receive the instruction to attentionally focus on their personal result in the performance test.
Further, they are asked to specify what would be personally good result for them.
We anticipated that after receiving this instruction, the expectation-disconfirming performance feedback should be salient for the participants, hence making it difficult for them to engage in cognitive immunization strategies.
|
Before working on the performance test, participants are instructed to pay attention to the feedback they receive.
In particular, they are asked to enter what would be a personally good result for them.
It is supposed that this shift of attention increases the salience of the expectation-disconfirming feedback.
|
|
EXPERIMENTAL: CONTROL
Participants in this condition receive no further information.
Therefore, they are passing through the standard procedure of the previously developed experimental paradigm.
|
This group does not receive any further intervention.
Instead, participants of this group pass through the standard procedure of the EXPEC paradigm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Performance Expectations Scale - generalized
Time Frame: Directly prior to the performance test and directly after completing the performance test
|
Change from Baseline to Postassessment in generalized performance expectations
|
Directly prior to the performance test and directly after completing the performance test
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Performance Expectations Scale - task-specific
Time Frame: Directly prior to the performance test and directly after completing the performance test
|
Change from Baseline to Postassessment in task-specific performance expectations
|
Directly prior to the performance test and directly after completing the performance test
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Tobias Kube, M. Sc., Philipps University Marburg Medical Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 14, 2017
Primary Completion (ACTUAL)
April 30, 2018
Study Completion (ACTUAL)
August 21, 2018
Study Registration Dates
First Submitted
January 29, 2018
First Submitted That Met QC Criteria
March 7, 2018
First Posted (ACTUAL)
March 9, 2018
Study Record Updates
Last Update Posted (ACTUAL)
August 23, 2018
Last Update Submitted That Met QC Criteria
August 22, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017-39k
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
No IPD will be shared
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Major Depressive Disorder
-
Gang WangWest China Hospital; The First Hospital of Hebei Medical University; Tianjin... and other collaboratorsRecruitingMajor Depressive Disorder (MDD) | Depression - Major Depressive DisorderChina
-
Brian MickeyNational Institute of Mental Health (NIMH)RecruitingMajor Depressive Episode | Depression - Major Depressive Disorder | Treatment-Resistant Major Depressive DisorderUnited States
-
Second Affiliated Hospital of Tsinghua UniversityNot yet recruiting
-
First People's Hospital of HangzhouNot yet recruitingMajor Depressive Disorder
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Recruiting
-
Shandong Provincial HospitalShandong UniversityRecruiting
-
Engrail Therapeutics INCCompletedMajor Depressive DisorderUnited Kingdom
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
Unity Health TorontoUniversity of Toronto; Toronto Metropolitan UniversityRecruitingMajor Depressive Disorder (MDD) | Major Depressive Episode | Treatment-Resistant Major Depressive DisorderCanada
-
Aalborg University HospitalRecruitingDepressive Disorder | Depression | Depressive Episode | Depressive Disorders | Depressive Episodes | Depression - Major Depressive Disorder | Depressive Disorder, Major Depressive DisorderDenmark
Clinical Trials on INFORMATION
-
University of North Carolina, Chapel HillDuke University; Agency for Healthcare Research and Quality (AHRQ)CompletedColorectal Cancer | Prostate Cancer | Osteoporosis | Preventive ScreeningUnited States
-
National Human Genome Research Institute (NHGRI)CompletedHealthy VolunteerUnited States
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedHealth CommunicationNorway
-
Meir Medical CenterCompletedChildhood ObesityIsrael
-
French Cardiology SocietyCompletedCardiac DiseaseFrance
-
ThinkWellUniversity of Oxford; Queen's University, Belfast; The BMJCompleted
-
University of MichiganUniversity of SydneyCompleted
-
Duke UniversityStanford University; University of North Carolina, Chapel Hill; World BankCompleted
-
Carnegie Mellon UniversityWithdrawn
-
Assaf-Harofeh Medical CenterUnknown